“…AKAP12 acts as a regulator of mitosis by anchoring key signaling proteins, such as PKA, PKC, and cyclins, thereby inhibiting the viability of tumor cells and inducing apoptosis via caspase-3 [ 4 , 9 , 10 ]. Notably, AKAP12 is reportedly downregulated in hepatocellular carcinoma (HCC) via promoter hypermethylation [ [11] , [12] , [13] , [14] ] and reduced in hepatic cirrhosis and precancerous lesions via upregulation of microRNA (miR)-183 and miR-186, which both target AKAP12. In addition, miR-1251-5p negatively regulates AKAP12 expression and plays a carcinogenic role in HCC [ 12 ].…”